DLL4 and cancer: In the case of general xenograft models using human cancer cell lines, we used the mouse surrogate version of ABL001 (mABL001: binding to human VEGF and mouse DLL4) for the studies, as DLL4 is expressed by mouse endothelial cells involving tumor angiogenesis in tumor xenografts [23].